UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 56

Sortiert nach

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma

Thorax, 2014-10, Vol.69 (10), p.895-902

2014

Volltextzugriff (PDF)

Gene of the month: BAP1

Journal of Clinical Pathology, 2016-09, Vol.69 (9), p.750-753

2016

Volltextzugriff (PDF)

Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma

Thorax, 2014-07, Vol.69 (7), p.638-647

2014

Volltextzugriff (PDF)

Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses

Journal of clinical pathology, 2016-08, Vol.69 (8), p.706-712

2016

Volltextzugriff (PDF)

Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA

Journal of Clinical Pathology, 2013-10, Vol.66 (10), p.854-861

2013

Volltextzugriff (PDF)

Inconsistent results or inconsistent methods? A plea for standardisation of biomarker sampling in mesothelioma studies

Thorax, 2015-04, Vol.70 (4), p.374-374

Blyth, Kevin G

2015

Volltextzugriff (PDF)

Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma

Journal for immunotherapy of cancer, 2020-06, Vol.8 (1), p.e000182

2020

Volltextzugriff (PDF)

Author's response: Inconsistent results or inconsistent methods? A plea for standardisation of biomarker sampling in mesothelioma studies

Thorax, 2015-04, Vol.70 (4), p.374-375

2015

Volltextzugriff (PDF)

Malignant deciduoid mesothelioma: a rare variant of epithelioid mesothelioma

BMJ case reports, 2019-07, Vol.12 (7), p.e229945

2019

Volltextzugriff (PDF)

CD24: a potential new marker in differentiating malignant mesothelioma from pulmonary adenocarcinoma

Journal of clinical pathology, 2013-03, Vol.66 (3), p.256-259

2013

Volltextzugriff (PDF)

The expression of Dishevelled-3 and glutamine metabolism in malignant pleural mesothelioma

Journal of clinical pathology, 2012-09, Vol.65 (9), p.855-858

2012

Volltextzugriff (PDF)

Preliminary data suggestive of a novel translational approach to mesothelioma treatment: imatinib mesylate with gemcitabine or pemetrexed

Thorax, 2007-08, Vol.62 (8), p.690-695

2007

Volltextzugriff (PDF)

Mesothelioma of the tunica vaginalis with BerEp4 and LeuM1 expression: identification of cytoplasmic tonofilaments by electron microscopy is a key diagnostic feature

Journal of clinical pathology, 2012-10, Vol.65 (10), p.958-959

2012

Volltextzugriff (PDF)

My approach to the diagnosis of mesothelial lesions

Journal of clinical pathology, 2006-06, Vol.59 (6), p.564-574

Butnor, K J

2006

Volltextzugriff (PDF)

Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies

Journal of clinical pathology, 2002-09, Vol.55 (9), p.662-668

2002

Volltextzugriff (PDF)

An EMA negative, desmin positive malignant mesothelioma: limitations of immunohistochemistry?

Journal of clinical pathology, 2009-07, Vol.62 (7), p.651-652

2009

Volltextzugriff (PDF)

Expression of GATA-6 transcription factor in pleural malignant mesothelioma and metastatic pulmonary adenocarcinoma

Journal of clinical pathology, 2009-04, Vol.62 (4), p.339-344

2009

Volltextzugriff (PDF)

Prognostic significance of cyclooxygenase-2 (COX-2) and expression of cell cycle inhibitors p21 and p27 in human pleural malignant mesothelioma

Thorax, 2004-05, Vol.59 (5), p.428-433

2004

Volltextzugriff (PDF)

Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival

Thorax, 2002-04, Vol.57 (4), p.353-356

2002

Volltextzugriff (PDF)

Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma

Thorax, 2003-12, Vol.58 (12), p.1077-1082

2003

Volltextzugriff (PDF)

Recurrent hypoglycaemia

Postgraduate medical journal, 1998-05, Vol.74 (871), p.279-281, Article 279

1998

Volltextzugriff (PDF)

Clearance of asbestos bodies from the lung: a personal view

British Journal of Industrial Medicine, 1980-08, Vol.37 (3), p.273-277

1980

Volltextzugriff (PDF)

Experimental study of the inhibition effect of CXCL12/CXCR4 in malignant pleural mesothelioma

Journal of investigative medicine, 2019-02, Vol.67 (2), p.338-345

2019

Volltextzugriff (PDF)

Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score

Thorax, 2014-12, Vol.69 (12), p.1098-1104

2014

Volltextzugriff (PDF)

Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers

Journal of Clinical Pathology, 2013-10, Vol.66 (10), p.847-853

2013

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Aktive Filter

PublikationsformNewsletter-Artikel

KollektionBMJ Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(56)

Sprache

Englisch
(56)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma

Gene of the month: BAP1

Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma

Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses

Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA

Inconsistent results or inconsistent methods? A plea for standardisation of biomarker sampling in mesothelioma studies

Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma

Author's response: Inconsistent results or inconsistent methods? A plea for standardisation of biomarker sampling in mesothelioma studies

Malignant deciduoid mesothelioma: a rare variant of epithelioid mesothelioma

CD24: a potential new marker in differentiating malignant mesothelioma from pulmonary adenocarcinoma

The expression of Dishevelled-3 and glutamine metabolism in malignant pleural mesothelioma

Preliminary data suggestive of a novel translational approach to mesothelioma treatment: imatinib mesylate with gemcitabine or pemetrexed

Mesothelioma of the tunica vaginalis with BerEp4 and LeuM1 expression: identification of cytoplasmic tonofilaments by electron microscopy is a key diagnostic feature

My approach to the diagnosis of mesothelial lesions

Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies

An EMA negative, desmin positive malignant mesothelioma: limitations of immunohistochemistry?

Expression of GATA-6 transcription factor in pleural malignant mesothelioma and metastatic pulmonary adenocarcinoma

Prognostic significance of cyclooxygenase-2 (COX-2) and expression of cell cycle inhibitors p21 and p27 in human pleural malignant mesothelioma

Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival

Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma

Recurrent hypoglycaemia

Clearance of asbestos bodies from the lung: a personal view

Experimental study of the inhibition effect of CXCL12/CXCR4 in malignant pleural mesothelioma

Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score

Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers

Aktive Filter

Suchergebnisse filtern